1-6 of 6
chimeric antigen receptor t-cell therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.
https://doi.org/10.1182/hematology.2019000068
Published: 2019
Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.
https://doi.org/10.1182/hematology.2019000370
Published: 2019
Journal Articles

Are CAR T cells better than antibody or HCT therapy in B-ALL?

Michael A. Pulsipher
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 16–24.
https://doi.org/10.1182/asheducation-2018.1.16
Published: 2018
Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.
https://doi.org/10.1182/asheducation-2018.1.9
Published: 2018
Journal Articles

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Noelle V. Frey, David L. Porter
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 567–572.
https://doi.org/10.1182/asheducation-2016.1.567
Published: 2016
Journal Articles

Chimeric antigen receptor T-cell therapy for ALL

Shannon L. Maude, Elizabeth J. Shpall, Stephan A. Grupp
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 559–564.
https://doi.org/10.1182/asheducation-2014.1.559
Published: 2014